Fresenius Kabi Oncol Company Profile
✉ Email this page to a colleague
What is the competitive landscape for FRESENIUS KABI ONCOL, and what generic and branded alternatives to FRESENIUS KABI ONCOL drugs are available?
FRESENIUS KABI ONCOL has two approved drugs.
Summary for Fresenius Kabi Oncol
US Patents: | 0 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 2 |
Patent Litigation for Fresenius Kabi Oncol: | See patent lawsuits for Fresenius Kabi Oncol |
Drugs and US Patents for Fresenius Kabi Oncol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Kabi Oncol | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 078810-001 | Aug 7, 2009 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Fresenius Kabi Oncol | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 078810-002 | Aug 7, 2009 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Fresenius Kabi Oncol | MITOXANTRONE HYDROCHLORIDE | mitoxantrone hydrochloride | INJECTABLE;INJECTION | 078606-001 | May 14, 2008 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Fresenius Kabi Oncol | MITOXANTRONE HYDROCHLORIDE | mitoxantrone hydrochloride | INJECTABLE;INJECTION | 078606-003 | May 14, 2008 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Fresenius Kabi Oncol | MITOXANTRONE HYDROCHLORIDE | mitoxantrone hydrochloride | INJECTABLE;INJECTION | 078606-002 | May 14, 2008 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.